We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential enable/disable

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name	Webedition CMS
Purpose	This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name	econda
Purpose	Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

Statistics enable/disable

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name	econda
Purpose	Statistics

External media enable/disable

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name	YouTube
Purpose	Show YouTube content
Name	Twitter
Purpose	activate Twitter Feeds

Research

Synergy Group 2

Group Functional multi-omics analysis of antiviral immunity and interactions of pandemic viruses with primary human lung tissue

Virus-induced pathology originates from molecular and cellular interactions, which are initiated by the virus in the host tissue. Here we combine the virus & proteomics expertise of the Pichlmair laboratory (TUM) with the single cell genomics and lung pathology expertise of the Schiller and Theis laboratories (HMGU) in order to generate pipelines that characterize virus-host interactions in complex tissues.
This data-driven approach will identify key regulators of antiviral immunity and immunopathology, which will be functionally evaluated. We anticipate that this approach will pinpoint options for antiviral therapies.

Andreas Pichlmair
andreas.pichlmair@tum.de

Herbert Schiller
herbert.schiller@helmholtz-muenchen.de

Fabian Theis
fabian.theis@helmholtz-muenchen.de